Artelo Biosciences Inc. June 30, 2025 - by Joey Ramson $ARTL is up over 200% after they announced positive results from its first-in-human Phase 1 Single Ascending Dose (SAD) study of ART26.12, a novel non-opioid pain treatment candidate. Share this article:
